Caribou Biosciences, Inc. (CRBU) has a market capitalization of $204.87M and trades at $2.12. The 52-week range is 0.66-3.535.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.3, Earnings Per Share (EPS) of $-1.59, annual revenue of $11.16M.
The stock has a beta of 2.46, operates in the Healthcare sector.
